CPRX - Catalyst: Upside Outlier - In Search Of A Catalyst May, 11 2022 01:27 AM Catalyst Pharmaceuticals Inc. Catalyst has outperformed during 2022 despite a brutal biotech market. Catalyst minds its knitting and does well by doing so. Catalyst reported strong earnings for Q1 2022. For further details see: Catalyst: Upside Outlier - In Search Of A Catalyst